Polymyositis Initiation Involving Amlodipine Besylate

dc.contributor.authorGolding, Raymund M
dc.contributor.authorGiles, Lynton G F
dc.contributor.authorSokoya, Elke Marion
dc.date.accessioned2014-09-30T06:10:33Z
dc.date.available2014-09-30T06:10:33Z
dc.date.issued2006
dc.description© 2006 R. M. Golding, L. G.F. Giles and E. M. Sokoya. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
dc.description.abstractBased on extensive blood pressure data and results from a scientific model of the analysis of the rate processes involved in polymyositis the evidence suggests that the polymyositis in a particular patient was initiated by taking the drug amlodipine besylate (norvasc). The method of our analysis should serve as a foundation in handling other drug related interactions.
dc.identifier.citationGolding, R.M., Giles, L.G. and Sokoya, E.M. (2006). Polymyositis Initiation Involving Amlodipine Besylate. American Journal of Immunology, 2(1) pp. 19-22.
dc.identifier.doihttps://doi.org/10.3844/ajisp.2006.19.22en
dc.identifier.issn1553-619X
dc.identifier.rmid2006017324
dc.identifier.urihttp://hdl.handle.net/2328/32714
dc.oaire.license.condition.licenseCC-BY
dc.publisherScience Publications
dc.rights© 2006 R. M. Golding, L. G.F. Giles and E. M. Sokoya
dc.rights.holder© 2006 R. M. Golding, L. G.F. Giles and E. M. Sokoya.
dc.subjectPolymyositis,
dc.subjectblood pressure
dc.subjectamlodipine besylate (norvasc)
dc.subjectsteroid therapy
dc.subject.forgroup1109 Neurosciences
dc.titlePolymyositis Initiation Involving Amlodipine Besylate
dc.typeArticle
local.contributor.authorOrcidLookupSokoya, Elke Marion: https://orcid.org/0000-0001-8509-2044en_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Golding_Polymyositis_P2006.pdf
Size:
101.97 KB
Format:
Adobe Portable Document Format
Description:
Publisher version